Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder

NCT00956085 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: Memantine

Sponsor

New York State Psychiatric Institute